NeuroSense Therapeutics (NRSN) Non-Current Assets (2020 - 2026)
NeuroSense Therapeutics' Non-Current Assets was $52,000 in Q2 2026, down 59.4% from $128,000 a year earlier.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Non-Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Assets at NeuroSense Therapeutics came in at $250,000, up 44.5% from FY2024.
- Non-Current Assets shows a five-year compound annual growth rate of 80.6% (FY2020 to FY2025).
- In earlier years, Non-Current Assets was $173,000 in FY2024 (-35.7%), $269,000 in FY2023 (-19.9%), $336,000 in FY2022 and $19,000 in FY2021 (+46.2%).
- The Q2 2026 figure marks the lowest quarterly Non-Current Assets since Q4 2021.
- Compared with a year earlier, Non-Current Assets was higher in 1 of the last five quarters, with an average decline of 24.4%.
- The best year-over-year quarter for Non-Current Assets over five years was Q4 2021 (growth of 46.2%); the worst was Q2 2026 (a decline of 59.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | NeuroSense Therapeutics | 3.19 Mn | -1.26 Mn | - | 52,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 52,000.00 |
| Dec 31, 2025 | 250,000.00 |
| Jun 30, 2025 | 128,000.00 |
| Dec 31, 2024 | 173,000.00 |
| Sep 30, 2024 | 199,000.00 |
| Jun 30, 2024 | 222,000.00 |
| Mar 31, 2024 | 254,000.00 |
| Dec 31, 2023 | 269,000.00 |
| Sep 30, 2023 | 281,000.00 |
| Jun 30, 2023 | 307,000.00 |
| Mar 31, 2023 | 317,000.00 |
| Dec 31, 2022 | 336,000.00 |
| Sep 30, 2022 | 338,000.00 |
| Jun 30, 2022 | 349,000.00 |
| Mar 31, 2022 | 329,000.00 |
| Dec 31, 2021 | 19,000.00 |
| Dec 31, 2020 | 13,000.00 |
API Access
NeuroSense Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();